Creative Financial Designs’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Sell |
2,971
-1,448
| -33% | -$92.8K | 0.01% | 498 |
|
|
2025
Q1 | $280K | Sell |
4,419
-894
| -17% | -$56.7K | 0.02% | 376 |
|
|
2024
Q4 | $353K | Sell |
5,313
-317
| -6% | -$21.1K | 0.03% | 339 |
|
|
2024
Q3 | $393K | Buy |
5,630
+299
| +6% | +$20.9K | 0.03% | 326 |
|
|
2024
Q2 | $346K | Buy |
5,331
+1,573
| +42% | +$102K | 0.03% | 329 |
|
|
2024
Q1 | $243K | Buy |
3,758
+411
| +12% | +$26.6K | 0.02% | 378 |
|
|
2023
Q4 | $220K | Buy |
3,347
+206
| +7% | +$13.6K | 0.02% | 370 |
|
|
2023
Q3 | $179K | Sell |
3,141
-107
| -3% | -$6.1K | 0.02% | 355 |
|
|
2023
Q2 | $199K | Buy |
3,248
+982
| +43% | +$60.2K | 0.02% | 342 |
|
|
2023
Q1 | $142K | Buy |
2,266
+281
| +14% | +$17.6K | 0.02% | 395 |
|
|
2022
Q4 | $126K | Sell |
1,985
-1
| -0.1% | -$63 | 0.02% | 406 |
|
|
2022
Q3 | $117K | Buy |
+1,986
| New | +$117K | 0.02% | 400 |
|